- Staat
- KS
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Febrile convulsion
Pyrexia
Symptomtext
Fever w/ simple febrile seizure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Febrile convulsion
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- history of febrile seizures
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 05.01.2022
- Impfdatum
- 05.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood glucose decreased
Dizziness
Fall
Symptomtext
Patient felt dizzy. Patient was out the store when fell over his left knee. He was consulted and haven't take food for a long period of time before being vaccinated (approx 7 hours). Apparently, it was related to a low level of blood glucose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 1,2
- Geschlecht
- M
- Eingang
- 18.11.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site swelling
Symptomtext
Patient and mother stayed in exam room after shots given to monitor for reactions, patient checked at 0857, noted to have an area of redness and slight swelling in are where varicella vaccine was given, mother states patient has not been scratching at this and does not seemed bothered by it, informed provider so she can view the site and mother agreed to stay in exam room for area to be monitored. Patient was checked again at 0908, raised area was same in size, area of redness slightly larger, provider viewed this and took a picture for documenting, mother states patient does not seemed bothered by it and is not scratching at it, patient and mother stayed in exam room and patient was checked again 0925, no changed in raised area and redness is the same,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 11.11.2021
- Impfdatum
- 11.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fear of injection
Feeling hot
Symptomtext
Prior to giving patient vaccines, she informed me that she "doesn't do well with shots sometimes." I gave patient her vaccines at 12:00 pm. At 12:02 pm, she reported feeling hot and dizzy. I had her lay down, turned on the fan, and put a cold wash cloth on her forehead. She reported feeling better immediately, and I got her a water bottle to drink. I had her lay down and rest for around 10 minutes. Patient's vital signs were stable during this time. After 10 minutes, she sat back up and stated she felt normal again. She declined EMS and me calling a family member or friend to drive her. I encouraged to continue drinking fluids and to rest for the rest of the day. Also, I instructed her to seek emergency care if she developed syncope, dyspnea, chest pain, or change in consciousness. She left the clinic in stable condition. I called her an hour and a half afterwards, and she stated she felt completely normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Excedrin prn (was taken in the morning)
- Allergien
- Amoxicillin- rash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Rash
Swelling face
Symptomtext
Rash and Facial Swelling on cheeks
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.01.2023
- Impfdatum
- 19.12.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AE details were provided and no additional AE's were reported; a dose of VARIVAX was administered intramuscularly instead of subcutaneously; This spontaneous report was received from a nurse referring to a patient of unknown gender and age. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies were not reported. On 19-DEC-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (0.5 milliliter, lot # U016065, expiration date reported in system, so no need to upon internal review and established as 20-MAY-2023, strength and frequency were not reported) intramuscularly instead of subcutaneously for prophylaxis (incorrect route of product administration). No additional AE details were provided and no additional adverse event (AE) were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.10.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Product storage error
Symptomtext
Onset date: 9/8/2022; No additional AE reported; Caller reported VARIVAX that had undergone temperature excursion was administered to a patient.; This spontaneous report was received from a nurse regarding a 1-day-old patient of unknown gender. There was no information about the patient's drug reactions or allergies, medical history, concurrent conditions, nor concomitant medications. On 08-SEP-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # U016065, expiration date 20-MAY-2022, (formulation, strength, dose, dose number, route of administration and anatomical site of vaccination were not reported) for prophylaxis (improper storage of product in use) (inappropriate age at vaccine administration). The vaccine administered was stored with an unknown temperature for a time frame of 1 hour and 45 minutes. It was not reported if a data logger was used. There was a previous temperature excursion. No additional adverse event (AE)were reported (no adverse event). This is one of several reports from the same reporter.; Sender's Comments: US-009507513-2210USA000872: US-009507513-2210USA000877: US-009507513-2210USA000999: US-009507513-2210USA001062: US-009507513-2210USA001209: US-009507513-2210USA001524: US-009507513-2210USA001533: US-009507513-2210USA001538: US-009507513-2210USA001904: US-009507513-2210USA000872:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 01.05.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 26,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
No additional AEs were reported.; The pharmacist stated that the patient received VARIVAX shorter than recommended interval. The patient received first dose of VARIVAX on 5/1/2022 and second dose on 5/27/2022.; This spontaneous report was received from pharmacist and referring to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, drugs reactions or allergies and concomitant medication were not provided. On 01-MAY-2022, the patient was vaccinated with a first dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter (ml) /dose, lot number u016065, expiration date: 20-MAY-2023 administered subcutaneously for prophylaxis (anatomical location was not provided). On 27-MAY-2022, the patient was vaccinated with a second dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5ml/dose, lot number u016065, expiration date: 20-MAY-2023, administered subcutaneously for prophylaxis (anatomical location was not provided) (inappropriate schedule of product administration). No adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.04.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; No other issues or concerns noted; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On an unknown date (reported as 20-MAY-2022), the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- 06.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 06-APR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 04-APR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- 28.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 28-MAR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- 31.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 31-MAR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date was confirmed as: 20-MAY-2023 (reported as 20-MAY-2022; exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.04.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 24-MAR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.04.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 24-MAR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.04.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 24-MAR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004064: US-009507513-2204USA004065: US-009507513-2204USA004066: US-009507513-2204USA004067: US-009507513-2204USA004068: US-009507513-2204USA004069: US-009507513-2204USA004070: US-009507513-2204USA004071:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 15.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient might have accidentally received Kinrix Lot H9Y52, expiration 1/31/22. There is currently no way to verify. Contacted manufacturer, GSK, who stated "results from in-house analytical potency testing have shown that Kinrix remains within the approved specifications for up to 30 days following the expiration date of the vaccine if stored under appropriate temperature and storage conditions." Based on this, the patient would not need to be re-vaccinated even if they did receive the expired vaccine, as it was administered within 30 days of vaccine expiration. No further action taken.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown.
- Vorgeschichte
- Unknown.
- Andere Medikamente
- Unknown.
- Allergien
- Unknown.
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 1,3
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported. No PQC; V ARlV AX was administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a 16-months-old patient of an unknown gender. Concomitant medications included measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and diluent (STERILE DILUENT). Patient's concurrent conditions, medical history and drug allergies were not provided. On 22-FEB-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot# U016065, expiration date 20-MAY-2023, at a dose 0,5 milliliter (route of administration and dose number were not provided) for prophylaxis (product storage error). The vaccine was reconstituted with properly stored diluent (STERILE DILUENT) on the same day. The varicella virus vaccine live (oka/merck) (VARIVAX) was stored at temperature 9.9F for 1 hour 22 minutes. No previous temperature excursion involved. No additional AE was reported. No PQC reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 10.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Pentacel given when only HIB was due. Provider spoke with parent - no known adverse reaction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.01.2022
- Impfdatum
- 30.12.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
This spontaneous report was received from an vaccine coordinator referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 30-DEC-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U016065, expiration date 20-MAY-2023) 0.5 mL (route, anatomical location and frequency not reported) for prophylaxis. The vaccine was stored at 8.1 degrees Celsius (C) for 2 hours, 58 minutes and 0 seconds. No previous temperature excursion were reported and it was unknown is a digital data logger was involved. No additional adverse events (AEs) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.11.2021
- Impfdatum
- 15.11.2021
- Beginn
- 15.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; doses of ROTATEQ, GARDASIL 9 and VARIVAX were administered following excursion; This spontaneous report was received from a nurse referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions, medical history and concomitant medications was not reported. On 15-NOV-2021, the patients were vaccinated with an unspecified number of doses of improperly stored of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # 1821247, expiration 23-JUL-2022 and lot # 1707471, expiration date 21-JUL-2022) orally (dose and frequency not reported), varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U016065, expiration date 20-MAY-2023) (dose, frequency and route not reported) and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (lot # T029523, expiration date 13-MAR-2023 and lot # T039466, expiration date 20-MAY-2023) (dose, frequency and route not reported), all administered for prophylaxis. The refrigerated products were stored at 29.1 degrees Celsius (C) for 8 hours and frozen products were stored at 25.5 C for 8 hours (Product storage error). It was not specified which products were stored at which temperature and the presence of a digital data logger was not reported. No additional adverse events (AEs) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
a patient received improperly stored V ARlV AX.; No additional AEs were reported; This spontaneous report was received from a Licensed Practical Nurse and refers to a currently 15-year-old patient of unknown gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided. On and unknown date, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 ml, (route of administration, anatomical location were not reported), lot # U016065 was confirmed to be valid, expiration date 20-MAY-2023 for prophylaxis. The temperature excursion was 0.3 degree Celsius (C) for 2 hours and 34 minutes; no previous temperature excursions were reported. No adverse symptoms were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2110USA006386: US-009507513-2110USA006418:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
The nurse is reporting that a patinet received improperly stored VARIVAX; No additional AE were reported; This spontaneous report was received from a Licensed Practical Nurse and refers to a 10-year-old patient of unknown gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided. On and unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (route of administration was not reported), lot # U016065 and expiration date 20-MAY-2023 administered as prophylaxis. The improperly stored dose of the suspect vaccine experienced a temperature excursion of 0.3 degree celsius (?C) for 2 hours and 34 minutes on an unknown date; no previous temperature excursions were reported. No adverse symptoms were reported. This is one of several reports received from the same reporter. As of 29-OCT-2021, all telephone attempts trying to obtain additional information has been unsuccessful. No further information is available.; Sender's Comments: US-009507513-2110CHN006820: US-009507513-2110USA006418: US-009507513-2110USA006855:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -